In the year 2003, Scott M.Rocklage was able to join 5AM Ventures as a Venture Partner. Soon after that, he was the managing partner of the company. Scott has an experience of over 30 years in the healthcare industry specifically the management area and has been able to see his leadership ways to guide the company well.
He used to be the president and the CEO of Nycomed Salutar and the chairman as well as the CEO of Cubist Pharmaceuticals. Scott also had positions at Catalytica and Salutar. Furthermore, he was the chairman of the board of Relypsa (NASDAQ: RLYP) as well as Novira. He presently serves as the board chairman of Cidara, Kinestral, and Rennovia.
Scott Rocklage achieved a B.S in Chemistry from the University of California, Berkeley and a Ph.D. in also chemistry from MIT. He has more than 100 publications that have been viewed and has been able to invent over 30 US copyrights. Scott is from Boston, MA Office.
5AM Ventures was established by Scott and his team because the firm was focusing on life science projects. They also had an objective of venture capital. Their business strategies are also great since the company is growing to greater heights.
Scott Rocklage’s day entails getting to understand fresh concepts of life science, working together with his team to make their portfolio a reality and attending board meetings.
He is dedicated to what he does, as a result, he teams up with business executives, scientists, and physicians to help them in discovering and inventing better medicine. Scott is enticed with the effort of having specific genotypes that assist in treating cancer in amazing ways.
Scott Rocklage is a successful man due to the following reasons; he always adheres to his priorities, he is time conscious and he obeys his daily schedule.
He is a wise man and accomplished who believes that if he was to start all over again he would focus more on individuals and choose a better team. Scott tells other entrepreneurs to embrace risk-taking because they will be able to work harder and overcome the challenge.
Read more: Scott Racklage | Crunchbase